Safety-Related Labeling Changes

Lithium: Concomitant use of an SGLT2 inhibitor with lithium may decrease serum lithium concentrations. Monitor serum lithium concentration more frequently during INVOKANA initiation and dosage changes.

Trade Name

Invokana

Updated Section

4.5. Interactions with other medicinal products

Month

Oct,2022